PE Anti-Cytokeratin 13 antibody [EPR3671]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal Cytokeratin 13 antibody - conjugated to PE. Suitable for Target Binding Affinity, Antibody Labelling, Flow Cyt (Intra), ICC/IF, IHC-P and reacts with Human samples.
View Alternative Names
Cytokeratin-13, Keratin-13, CK-13, K13, KRT13
Related conjugates and formulations (9)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Cytokeratin 13 antibody [EPR3671]
-
HRP Anti-Cytokeratin 13 antibody [EPR3671]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Cytokeratin 13 antibody [EPR3671]
-
660 APC
APC Anti-Cytokeratin 13 antibody [EPR3671]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Cytokeratin 13 antibody [EPR3671]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Cytokeratin 13 antibody [EPR3671]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-Cytokeratin 13 antibody [EPR3671]
-
Anti-Cytokeratin 13 antibody [EPR3671]
-
Anti-Cytokeratin 13 antibody [EPR3671] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein participates in maintaining the structural framework and dynamics within epithelial tissues. As part of the cytoskeletal complex cytokeratin 13 supports cellular resilience against mechanical stress. It interacts with other cytokeratins contributing to the formation of a robust keratin filament network essential for epithelial cell function and differentiation. Its expression and regulation are key to the homeostasis of the tissues where it is found ensuring proper cell division and tissue integrity.
Pathways
Cytokeratin 13 integrates into epithelial cell differentiation and repair processes. It is involved in the epithelial-mesenchymal transition (EMT) pathway important for tissue development wound healing and cancer metastasis. During the EMT process cytokeratin 13 often works alongside proteins like E-cadherin and Vimentin mediating changes in epithelial cell architecture and polarity. This modulation is essential for cellular plasticity and response to environmental cues.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com